Ebola virus outbreak, updates on current therapeutic strategies

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Filoviruses, including Ebola and Marburg viruses, are single-stranded RNA viruses responsible for hemorrhagic fevers with up to 90% case fatality.
• The 2013-2015 West Africa Ebola epidemic was the largest on record, resulting in over 10,000 deaths and highlighting the urgent need for effective treatments.

Purpose of the Study:

• To review the nature, classification, and replication of filoviruses.
• To discuss disease transmission, viral entry mechanisms, and current therapeutic development for controlling outbreaks.

Main Methods:

• Review of existing literature on filovirus biology and outbreaks.
• Analysis of current research on therapeutic interventions, including vaccines and antiviral agents.
• Highlighting the efficacy of monoclonal antibody cocktails in preclinical models.

Main Results:

• Filoviruses pose a significant public health threat due to high mortality and rapid spread.
• Several therapeutic strategies, including vaccines and antiviral small molecules, show promise.
• Monoclonal antibodies have demonstrated high efficacy in protecting non-human primates.

Conclusions:

• The development of potent and safe therapeutics is crucial for combating current and future filovirus outbreaks.
• Continued research into viral mechanisms and therapeutic interventions is essential.
• A multi-pronged approach involving vaccines and targeted therapies is needed for effective control.